Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Ambee Pharmaceuticals Income Statement

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	193.9	230.55	219.3	198.1	180.99	98.98
Revenue Growth (YoY)	-16.50%	5.13%	10.71%	9.45%	82.86%	-65.31%
Cost of Revenue	102.17	119.16	103.14	92.53	83.62	58.27
Gross Profit	91.72	111.39	116.16	105.56	97.37	40.71
Selling, General & Admin	84.94	104	103.75	92.39	82.51	47.99
Operating Expenses	84.94	104	103.75	92.39	82.51	47.99
Operating Income	6.78	7.39	12.41	13.17	14.86	-7.28
Interest Expense	-0.07	-0.09	-0.58	-2.49	-4.62	-5
Other Non Operating Income (Expenses)	-0	-	0	-0	-	0
EBT Excluding Unusual Items	6.71	7.3	11.83	10.68	10.23	-12.28
Pretax Income	6.71	7.3	11.83	10.68	10.23	-12.28
Income Tax Expense	1.89	1.99	2.15	1.59	2.18	0.73
Net Income	4.82	5.31	9.68	9.09	8.06	-13.01
Net Income to Common	4.82	5.31	9.68	9.09	8.06	-13.01
Net Income Growth	-51.41%	-45.17%	6.53%	12.79%	-	-
Shares Outstanding (Basic)	2	2	2	2	2	2
Shares Outstanding (Diluted)	2	2	2	2	2	2
EPS (Basic)	2.01	2.21	4.03	3.79	3.36	-5.42
EPS (Diluted)	2.01	2.21	4.03	3.79	3.36	-5.42
EPS Growth	-51.41%	-45.17%	6.53%	12.79%	-	-
Free Cash Flow	-8.9	-2.06	-68.12	-35.34	-74.71	-5.45
Free Cash Flow Per Share	-3.71	-0.86	-28.39	-14.72	-31.13	-2.27
Dividend Per Share	1.000	1.000	1.000	1.500	1.000	-
Dividend Growth	-	-	-33.33%	50.00%	-	-
Gross Margin	47.30%	48.31%	52.97%	53.29%	53.80%	41.13%
Operating Margin	3.50%	3.21%	5.66%	6.65%	8.21%	-7.36%
Profit Margin	2.49%	2.30%	4.42%	4.59%	4.45%	-13.14%
Free Cash Flow Margin	-4.59%	-0.89%	-31.06%	-17.84%	-41.28%	-5.51%
EBITDA	-	12.46	18.26	20.16	19.64	-1.67
EBITDA Margin	-	5.40%	8.32%	10.18%	10.85%	-1.69%
D&A For EBITDA	-	5.07	5.84	6.99	4.79	5.61
EBIT	6.78	7.39	12.41	13.17	14.86	-7.28
EBIT Margin	3.50%	3.20%	5.66%	6.65%	8.21%	-7.36%
Effective Tax Rate	28.21%	27.26%	18.16%	14.90%	21.25%	-
Advertising Expenses	-	0.82	1.12	1.43	4.58	0.93

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.